Shah Preetam — SEC Form 4 filings

SEC reporting owner CIK 1787403. 6 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-12 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cidara Therapeutics, Inc. (CDTX)Chief Financial Officer31 leg · 18,931 sh · $12,6803
Elicio Therapeutics, Inc. (ELTX)See Remarks34

Form 4 filings — Shah Preetam

FiledFormIssuerReported transactionsSource
2026-07-174Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 60,833 (derivative) @ $0EDGAR
2026-02-034Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 24,000 @ $0 · Grant/award (A): 47,900 (derivative) @ $0EDGAR
2025-04-164Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 191,624 (derivative) @ $0EDGAR
2024-10-024Cidara Therapeutics, Inc. (CDTX)Grant/award (A): 130,087 (derivative) @ $0EDGAR
2024-03-204Cidara Therapeutics, Inc. (CDTX)Grant/award (A): 108,750 @ $0 · Grant/award (A): 217,500 (derivative) @ $0EDGAR
2024-03-124Cidara Therapeutics, Inc. (CDTX)Sale (S): 18,931 @ $0.67EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1787403 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →